Chris Beddard[email protected]InfectiousThe next phase of diagnostic testing is here and ready to scaleIt is time to provide more advanced insight on patient health and more informed treatment options for clinicians in the U.S. Few diagnostic tools and systems on the market today are available to scale and even fewer provide extended genotyping capabilities. This gap can hamper patient care by masking or misdiagnosing illnesses and strains, potentially leading physicians to advise treatment plans that lack precision or that may be unnecessary.November 10, 2021Page 1 of 1Top StoriesMonkeypoxSeegene launches 3rd RUO mpox assayAfter introducing two research use only (RUO) mpox assays in August, Seegene has expanded its mpox assay line with a third RUO assay designed to address the spread of the mpox virus variant clade Ib currently prevalent in the mpox outbreak in Africa.Policy and RegulationHospital labs targeted in proposed Calif. hospital licensing regulationsResearch GrantHudsonAlpha Institute gets $2.9M NIH grant for pediatric rare disease sequencingClinical ChemistryADLM releases guidance for blood lipid assessment, lipoprotein testingSponsor ContentVisit our Molecular Diagnostics Community